InsiderFlow

ABUS

Arbutus Biopharma Corp$5.01+0.01 (+0.30%)
Prev Close$5.00·MCap$997.6M·P/E6.09·Vol4.21M·Yield

Buys (12M)

0

$0.00

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$0.00

Active Insiders

0

last 12 mo

ABUS Insider Trading Activity

DateInsiderTypeValue
Feb 4, 2025 HASTINGS DAVID CSell$72.8K
Feb 4, 2025 McElhaugh Michael J.Sell$78.1K
Feb 4, 2025 Naftzger J. ChristopherSell$37.2K
Feb 4, 2025 Sims KarenSell$63.5K
Aug 14, 2024 MANCHESTER KEITH SSell$32.6K
Feb 1, 2024 HASTINGS DAVID CSell$22.2K
Feb 1, 2024 McElhaugh Michael J.Sell$23.5K
Feb 1, 2024 Sims KarenSell$10.1K
Feb 1, 2024 Sofia Michael J.Sell$23.1K
Dec 1, 2021 Sofia Michael J.Sell$1.02M

ABUS Insider Buying Activity

The following table shows recent insider purchases of Arbutus Biopharma Corp (ABUS) stock reported via SEC Form 4 filings.

No insider buying activity found for ABUS in the last 12 months.

ABUS Insider Selling Activity

The following table shows recent insider sales of Arbutus Biopharma Corp (ABUS) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Feb 4, 2025 HASTINGS DAVID CSell$72.8K
Feb 4, 2025 McElhaugh Michael J.Sell$78.1K
Feb 4, 2025 Naftzger J. ChristopherSell$37.2K
Feb 4, 2025 Sims KarenSell$63.5K
Aug 14, 2024 MANCHESTER KEITH SSell$32.6K
Feb 1, 2024 HASTINGS DAVID CSell$22.2K
Feb 1, 2024 McElhaugh Michael J.Sell$23.5K
Feb 1, 2024 Sims KarenSell$10.1K
Feb 1, 2024 Sofia Michael J.Sell$23.1K
Dec 1, 2021 Sofia Michael J.Sell$1.02M

ABUS Insiders

McElhaugh Michael J.

Interim President & CEO

Sold $101.6K
2 tradesLast: Feb 4, 2025
Naftzger J. Christopher

General Counsel and CCO

Sold $37.2K
1 tradesLast: Feb 4, 2025
HASTINGS DAVID C

Chief Financial Officer

Sold $95.0K
2 tradesLast: Feb 4, 2025
Sims Karen

Chief Medical Officer

Sold $73.6K
2 tradesLast: Feb 4, 2025
MANCHESTER KEITH S

Director

Sold $32.6K
1 tradesLast: Aug 14, 2024
Sofia Michael J.

Chief Scientific Officer

Sold $1.04M
2 tradesLast: Feb 1, 2024